tradingkey.logo

cbdMD Inc

YCBD
0.923USD
-0.021-2.21%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
8.23MCap. mercado
PérdidaP/E TTM

Más Datos de cbdMD Inc Compañía

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Información de cbdMD Inc

Símbolo de cotizaciónYCBD
Nombre de la empresacbdMD Inc
Fecha de salida a bolsaNov 17, 2017
Director ejecutivoKennedy (T. Ronan)
Número de empleados42
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 17
Dirección8845 Red Oak Blvd
CiudadCHARLOTTE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal28217-5593
Teléfono17044453060
Sitio Webhttps://www.cbdmd.com/
Símbolo de cotizaciónYCBD
Fecha de salida a bolsaNov 17, 2017
Director ejecutivoKennedy (T. Ronan)

Ejecutivos de cbdMD Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
1.83K
-393.00%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
1.75K
-373.00%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
1.83K
-393.00%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
1.75K
-373.00%
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
E-commerce sales
14.72M
76.68%
Wholesale sales
4.48M
23.32%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
E-commerce sales
14.72M
76.68%
Wholesale sales
4.48M
23.32%

Estadísticas de accionistas

Actualizado: lun., 2 de feb
Actualizado: lun., 2 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Porter (Jeffrey H)
5.48%
Crc Investment Fund LP
4.16%
CSS, LLC
1.36%
The Vanguard Group, Inc.
0.94%
Chapin Davis Asset Management
0.77%
Otro
87.30%
Accionistas
Accionistas
Proporción
Porter (Jeffrey H)
5.48%
Crc Investment Fund LP
4.16%
CSS, LLC
1.36%
The Vanguard Group, Inc.
0.94%
Chapin Davis Asset Management
0.77%
Otro
87.30%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
6.43%
Investment Advisor
4.22%
Corporation
4.16%
Investment Advisor/Hedge Fund
0.13%
Otro
85.06%

Participación institucional

Actualizado: mié., 21 de ene
Actualizado: mié., 21 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
33
436.16K
5.38%
--
2025Q4
53
457.02K
4.35%
-122.38K
2025Q3
51
502.25K
5.64%
+188.29K
2025Q2
61
1.71M
19.14%
+1.55M
2025Q1
80
154.62K
3.22%
-19.13K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Porter (Jeffrey H)
73.26K
0.78%
+73.26K
--
May 16, 2025
Crc Investment Fund LP
436.15K
4.63%
-797.41K
-64.64%
Dec 17, 2025
CSS, LLC
142.62K
1.51%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
51.56K
0.55%
+51.56K
--
Sep 30, 2025
Chapin Davis Asset Management
121.55K
1.29%
+2.92K
+2.47%
Sep 30, 2025
Kennedy (Thomas Ronan)
454.31K
4.82%
+445.00K
+4778.27%
Nov 28, 2025
Alesco Advisors LLC
68.51K
0.73%
--
--
Sep 30, 2025
Roe (Kevin Charles)
4.52K
0.05%
+4.52K
--
May 16, 2025
Commonwealth Financial Network
16.25K
0.17%
--
--
Sep 30, 2025
Scientech Research LLC
15.41K
0.16%
+15.41K
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Cambria Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Amplify Seymour Cannabis ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 21, 2025
Merger
8→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
Apr 14, 2023
Merger
45→1
KeyAI